Combined homologous repair deficiency and #immune activation analysis for predicting #chemotherapy responses in triple negative #BreastCancer Read it here: https://t.co/bx7jrOdIeM https://t.co/plW8SVTUUc
Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer by Gaoming Liao https://t.co/0aHYkIuqg9
New article: Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer https://t.co/5Gj5ZSjEvD #breast
Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer https://t.co/Zs5NmNdPE8